Cannabidiol - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for cannabidiol and what is the scope of patent protection?

Cannabidiol is the generic ingredient in one branded drug marketed by Gw Res Ltd and is included in one NDA. There are ten patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Cannabidiol has fifty-eight patent family members in fifteen countries.

There are nine drug master file entries for cannabidiol. One supplier is listed for this compound.

Summary for cannabidiol

International Patents:	58
US Patents:	10
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	9
Suppliers / Packagers:	1
Bulk Api Vendors:	30
Clinical Trials:	176
Patent Applications:	3,371
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for cannabidiol
DailyMed Link:	cannabidiol at DailyMed

Recent Clinical Trials for cannabidiol

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
MGC Pharmaceuticals d.o.o	Phase 2
University of California, San Diego	Phase 3
Center for Medicinal Cannabis Research	Phase 3

See all cannabidiol clinical trials

US Patents and Regulatory Information for cannabidiol

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Gw Res Ltd	EPIDIOLEX	cannabidiol	SOLUTION;ORAL	210365-001	Sep 28, 2018		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
Gw Res Ltd	EPIDIOLEX	cannabidiol	SOLUTION;ORAL	210365-001	Sep 28, 2018		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
Gw Res Ltd	EPIDIOLEX	cannabidiol	SOLUTION;ORAL	210365-001	Sep 28, 2018		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
Gw Res Ltd	EPIDIOLEX	cannabidiol	SOLUTION;ORAL	210365-001	Sep 28, 2018		RX	Yes	Yes	Start Trial	Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for cannabidiol

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Brazil	112017007777	Start Trial
World Intellectual Property Organization (WIPO)	2015193668	Start Trial
Japan	2017519758	Start Trial
European Patent Office	1385595	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.